Innovative Pre-clinical Research

Synovo is a drug discovery company with a primary focus on inflammation and innate immune processes.
We are located in Tübingen, Germany which is both a major centre for basic research and also home to a vibrant bio-medical start-up scene.
We have two main business areas:

  • we provide drug discovery services in pharmacology, medicinal chemistry and bioanalytics, and,
  • we develop in-house novel therapeutics and related diagnostics

Our culture is focused on generating insight through inter-disciplinary, collaborative work with clients and partners.   
Within our team of nearly 50 people we have specialists in synthetic chemistry, pharmacology, analytics, immunology, neurology and biochemistry.  In addition, we have a broad network of research partners throughout the world collaborating with us in areas like basic disease mechanisms, drug formulation technology, surface modification and drug mode of action.

We welcome enquiries and we are proud of our reputation for helping colleagues and partners achieve their research goals. 

What we do

PHARMACEUTICAL SERVICES

Synovo offers the possibility of improving your pre-clinical data set. Take the opportunity to explore deeper parameters and learn more from your studies by adding our services to your projects.

 

 

Learn more about our

SERVICES

 

 

INNOVATION

We are committed to contribute to health improvement by developing novel therapeutic options for global unmet needs.

 

 

 

Learn more about our

PROJECTS

 

TEAM

The Synovo family shares a common interest toward developing science-driven mind changing ideas, by interdisciplinary and creative team work. Moreover we are aware of our place in the local community, trying to exemplify an active lifestyle.

 

Learn more about our

TEAMSCIENCE

Latest news

News from our Infection Department

Together with our colleagues from Amsterdam and Leiden, we have taken a […]

WCI 2022 Rome

After two years of absence the World Congress on Inflammation took place […]

Publication Highlight: Novel JAK3 Inhibitor

One of our premier internal research projects involves the development of novel, […]

See all our news

We believe in

  • Research commitment. Users/patients focus. Quality and reliability.
  • Respect and integrity. Work-life balance.
  • Diversity.
  • Interdisciplinary team. Open and constant flow of knowledge.
  • Collaborative leadership. Transparent networking.
  • Flexibility and Creative Innovation. Challenge acceptance.
  • Education and training. Modern and traditional methods.
  • Personal growth and initiative.
Join in